title: [Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab: a case description and literature review].
authors.forename: Diego
authors.initials: D
authors.lastname: Moreno
authors.forename: Pedro
authors.initials: P
authors.lastname: Martínez
authors.forename: Juan
authors.initials: J
authors.lastname: Berbegal
authors.forename: Miguel
authors.initials: M
authors.lastname: Femenia
mesh_terms: D000068879:Adalimumab; D000368:Aged; D000818:Animals; D000829:Animals, Domestic / Q000469:parasitology; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D001853:Bone Marrow / Q000469:parasitology; D002415:Cats; D004197:Disease Reservoirs / Q000469:parasitology; D004283:Dog Diseases / Q000635:transmission; D004285:Dogs / Q000469:parasitology; D004359:Drug Therapy, Combination; D004386:Duodenum / Q000469:parasitology; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D055985:Latent Tuberculosis / Q000150:complications; D007898:Leishmaniasis, Visceral / Q000209:etiology* / Q000635:transmission / Q000662:veterinary; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D009288:Naproxen / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D009288:Naproxen; D000068879:Adalimumab; D011241:Prednisone; D008727:Methotrexate